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Abstract
Background: Persons who default from tuberculosis treatment are at risk for clinical deterioration and
complications including worsening drug resistance and death. Our objective was to identify risk factors associated
with tuberculosis (TB) treatment default in South Africa.
Methods: We conducted a national retrospective case control study to identify factors associated with treatment
default using program data from 2002 and a standardized patient questionnaire. We defined default as interrupting
TB treatment for two or more consecutive months during treatment. Cases were a sample of registered TB patients
receiving treatment under DOTS that defaulted from treatment. Controls were those who began therapy and were
cured, completed or failed treatment. Two respective multivariable models were constructed, stratified by history of
TB treatment (new and re-treatment patients), to identify independent risk factors associated with default.
Results: The sample included 3165 TB patients from 8 provinces; 1164 were traceable and interviewed (232 cases
and 932 controls). Significant risk factors associated with default among both groups included poor health care
worker attitude (new: AOR 2.1, 95% CI 1.1-4.4; re-treatment: AOR 12, 95% CI 2.2-66.0) and changing residence
during TB treatment (new: AOR 2.0, 95% CI 1.1-3.7; re-treatment: AOR 3.4, 95% CI 1.1-9.9). Among new patients,
cases were more likely than controls to report having no formal education (AOR 2.3, 95% CI 1.2-4.2), feeling
ashamed to have TB (AOR 2.0, 95% CI 1.3-3.0), not receiving adequate counseling about their treatment (AOR 1.9,
95% CI 1.2-2.8), drinking any alcohol during TB treatment (AOR 1.9, 95% CI 1.2-3.0), and seeing a traditional healer
during TB treatment (AOR 1.9, 95% CI 1.1-3.4). Among re-treatment patients, risk factors included stopping TB
treatment because they felt better (AOR 21, 95% CI 5.2-84), having a previous history of TB treatment default
(AOR 6.4, 95% CI 2.9-14), and feeling that food provisions might have helped them finish treatment (AOR 5.0, 95%
CI 1.3-19).
Conclusions: Risk factors for default differ between new and re-treatment TB patients in South Africa. Addressing
default in both populations with targeted interventions is critical to overall program success.
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Background
In 2002, South Africa ranked 9th worldwide in terms of
total number of tuberculosis (TB) cases and 8th in
terms of the highest TB incidence rates per capita. The
incidence of all reported TB cases had increased 2.5 fold
between 1992 (228/100,000) and 2002 (558/100,000) [1].
By 2001, TB was the leading reported cause of death by
natural causes [2]. While case detection and implemen-
tation of DOTS increased substantially during this time
frame, by 2002, treatment success rates remained low
(65% for new cases and 53% for re-treatment cases), and
default (12% for new cases and 17% for re-treatment
cases) and death (7% for new cases and 9% for re-treat-
ment cases) rates high [1].
Persons under treatment for TB who default from
treatment are at risk for clinical deterioration and com-
plications, can continue to be infectious to others, and
are at risk of premature death from TB [3]. There are
limited studies on the risk factors associated with TB
treatment default in S. Africa under DOTS [4-7]. Having
had a history of TB treatment has been associated with
TB treatment default [8-10]. South Africa faces unique
challenges with an unparalleled co-epidemic of TB and
human immunodeficiency virus (HIV), in the setting of
an overburdened health-service sector. There are com-
plex economic and environmental conditions, including
high levels of urban migration and unemployment, and
unique socio-cultural risk factors that may have impor-
tant influences on TB treatment adherence. The relative
contribution of these factors to the problem of default
from TB treatment is not known. We performed a ret-
rospective case-control study to evaluate risk factors for
default from TB treatment in 8 of 9 provinces in South
Africa in 2002. Our primary objective was to identify
patient-level and provider-level risk factors associated
with default from TB treatment.
Methods
We conducted a questionnaire-based, case-control study
among adult persons ≥ 18 years old enrolled in treat-
ment under DOTS at public health facilities in South
Africa between January 1 and December 31, 2002. Eligi-
ble cases were defined as any new and re-treatment TB
patient (with pulmonary or extrapulmonary TB) who
were on treatment for at least 4 weeks, then defaulted
from a six-month (new) or eight-month (re-treatment)
TB regimen. New patients received a fixed dose combi-
nation Rifafour
® (isoniazid, rifampin, pyrazinamide,
ethambutol), retreatment cases received Rifafour
® plus
streptomycin injection.
We defined default as interrupting TB treatment for
two or more consecutive months during treatment. Eli-
gible controls were those persons diagnosed with TB
who began therapy and were cured, completed or failed
treatment. Persons were excluded if they were recorded
to have died or transferred, were younger than 18 years,
were known to have multidrug-resistant TB or were
prisoners or wards of the state.
Interviewers were trained to review medical records
available at the health facilities, and to trace and inter-
view TB patients with written informed consent. Inter-
viewers made every effort to locate patients using
information available from the health center records or
staff who knew the patients; they telephoned patients,
located their homes if possible and made multiple visits
if necessary. In the event a patient no longer lived at a
specific address, they asked local neighbors and guides
to help them trace the patients. To minimize bias, the
interviewers did not know the patients and were not
associated with the local health services. Data collected
from the health facilities included demographic informa-
tion, patient’s address, treatment information including
dates of TB registration, treatment initiation and com-
pletion and treatment outcome.
A structured questionnaire was adapted from a ques-
tionnaire previously used in South Africa to study MDR
TB adherence, with additional questions concerning the
role of food and nutrition during TB treatment [6].
Questions covered five domains commonly cited regard-
ing adherence to long-term therapies (Figure 1) [11].
The questionnaire was pre-tested and translated from
English into 10 South African home languages (Xit-
songa, Tshivenda, Siswati, Setswana, Sesotho, IsiZulu,
IsiXhosa, IsiNdebele, Afrikaans) and back-translated into
English to ensure the quality of translation. The
Domains of Adherence [11]
x Social and economic factors
x Patient-related factors
x Condition-related factors
x Therapy-related factors
x Health care team and system-
related factors
Figure 1 Domains of adherence.
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yes/no and open-ended questions on demographic,
social, health service and treatment characteristics. We
inquired about the provision of nutritional support and
the role of enablers and incentives. Information on the
HIV status of persons with TB was not included as HIV
services were not integrated in the TB program in 2002.
Questionnaires were administered in the TB patient’s
home language using face-to-face interviews. Inter-
viewers were trained to encourage defaulters to return
t ot h eh e a l t hc l i n i ct ob ee v a l u a t e df o rT Bt r e a t m e n t .
For patients who were found to have died, the outcome
of death, date of death and cause, if available, was
recorded. Patients were given a standard food parcel
equivalent to approximately US$15 for participating in
the study, offered after the informed consent and inter-
view so as to not bias study participation or responses.
The sample was selected from facility-based national
T Br e g i s t e r si n8p r o v i n c e sa n dm a t c h e db yq u a r t e ro f
enrolment and health facility at a ratio of 1 case: 2 con-
trols. TB registers from Limpopo province were not
available and thus excluded. Sample selection for each
province was conducted by multi-stage sampling made
up of urban and rural sub-samples that reflected the
estimated demographic population proportions reported
for 2001. For each province, we compiled a list of all
urban and rural public clinics including number of new
patients enrolled and number of defaulters in 2002. The
health facility sub-samples were chosen by systematic
sampling proportional to clinic enrolment size. TB regis-
ters were requested from selected health facilities and
the pre-calculated number of cases and matched con-
trols were selected randomly from the TB registers.
Based on historic program data on the proportion of
patients from each province classified as re-treatment
patients (8-27% depending on the province), we calcu-
lated a sample size large enough to show at least a 25%
difference between cases and controls that would result
in a statistically significant odds ratio (OR) of > 2.9 with
a 95% confidence interval (CI) and a power of 80%, for
each province. In anticipation of difficulties associated
with finding defaulters, the overall sample size was
increased by 75%. Based on these calculations, the tar-
geted sample size for the 8 provinces was 1055 cases
and 2110 controls.
Data were entered into an EpiData v.3.1 database and
analyzed with STATA 8 [12,13]. Data were validated by
checking consistency values, evaluating range values, and
performing uniqueness checks. We analyzed differences
in proportions using the Mantel-Haenszel chi-square sta-
tistic (c
2)o rF i s h e r ’s exact test where appropriate. For
data not normally distributed, we compared differences
in medians using the Wilcoxon rank-sum test. We per-
formed multivariable logistic regression analysis with
forward selection. We evaluated all variables in the
b i v a r i a t ea n a l y s i st h a tw e r es i g n i f i c a n ta tP <0 . 2 0i nt h e
multivariable analysis using logistic regression for the
final models. For all statistical tests, we considered a P
value of < 0.05 as statistically significant. All pair wise
interactions of the explanatory variables that were epide-
miologically relevant in the model were considered.
Ethics statement
This study was approved by the Ethics Committee of
the South African Medical Research Council and the
respective provincial research committees. This study
was also approved as human subjects’ research by the
Institutional Review Board at the US Centers for Disease
Control and Prevention in Atlanta, GA, USA. Voluntary
written informed consent was obtained from all partici-
pants included in the study.
Results
We collected data between July 2004 and August 2005.
Of 3165 patients sampled, health records were available
for 3079 (97%). Of these, we successfully traced and
interviewed 1164 (232 cases and 932 controls, 26% and
43% respectively) (Figure 2). Few patients refused to be
interviewed (34 patients, 1%). An additional 1319/3079
(43%) patients could not be traced, due to incorrect
addresses listed in health facility records or were not eli-
gible. A large proportion (18%) of patients were found
to have died, including 210/900 (23%) cases and 352/
2179 (16%) controls (P < 0.001). The date of death was
known for 115/200 (55%) cases. Of these, 33 (22%) were
reported to have died within 2 months after stopping
TB treatment before completion (no data on when dur-
ing treatment). These patients were probably misclassi-
fied as defaulters, and were likely deaths.
Limited clinical data were available from patients who
were not interviewed. Cases interviewed vs. not inter-
viewed were more likely to be younger, to have attended
a rural clinic, to be a re-treatment patient, and to
default later in the treatment course. Controls inter-
viewed vs. not interviewed were more likely to have
attended a rural clinic, to be a re-treatment patient and
less likely to have been admitted to an inpatient health-
care facility for TB treatment. Patients who were not
interviewed were excluded from further analysis.
We explored factors associated with default, stratified
among new and re-treatment patients. Among the 1164
patients interviewed, 2/1164 had an unknown patient
category and were excluded from the analysis. Tables 1,
2 and 3 summarize the main characteristics from the
health facility record review and interviews with 1162
patients (231 cases and 931 controls) who had a known
patient category, were successfully traced, and consented
to participate.
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Table 1 shows the age distribution and sex of patients,
stratified by patient category, new and re-treatment
patients. Among new patients, cases were more likely to
be male (OR 1.5, 95% CI 1.1-2.2). Among both new and
retreatment patients, the median age of cases was
younger than controls. Most patients were born in
South Africa, single, black African, reported practicing
religion, and had one or more children (Table 2).
Unemployment was common and similar between
groups (47% of cases and 52% of controls). Among
employed patients, default was associated with patients
missing treatment due to employment. Reasons cited by
patients included that they were too busy and did not
have enough time, work was too far from the TB clinic,
employer did not allow them to get TB treatment and
3079 (97%) patients with 
initial health facility record review  
1164 (38%) traced and interviewed 
232 cases : 932 controls 
562 (18%) traced, had 
died  
(210 cases, 352 controls)  
1319 (43%) patients could 
not be traced or were not 
eligible  
3165 patients selected 
No health records  
available for 86 (3%) 
patients 
34 (1%) traced, refused to 
participate, not 
interviewed 
Figure 2 Interview rate.
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Page 4 of 12some patients did not want other co-workers to know
they had TB.
Among new TB patients, cases were more likely than
controls to be male, to lack formal education, to have
changed residence during TB treatment, to be a laborer,
and to have missed treatment due to employment.
Among re-treatment TB patients, cases were more likely
than controls to have changed residence during TB treat-
ment and to have missed treatment due to employment.
New and re-treatment cases and controls were similar in
terms of feeling ashamed, seeing a traditional healer,
alcohol use, and experiencing side effects (Table 3).
Patient-related factors
Most patients reported having told someone about their
TB diagnosis, and these findings were similar between
cases and controls. However, among both new and re-
treatment groups, cases were more likely than controls
to report feeling shame or embarrassment about having
TB (Table 3). Defaulters were also more likely than con-
trols to report that they did not feel better with treat-
ment. Among new TB patients, cases were less likely
than controls to have felt supported by their family dur-
ing TB treatment. Reported causes of TB were similar
between groups; although, some incorrect causes were
commonly cited by both cases and controls including
“witchcraft” and “taboo”. The majority of cases and con-
trols reported that they originally thought they would
have finished taking treatment, felt that TB was curable,
and that they could die from TB if not treated.
Therapy and condition-related factors
New and re-treatment cases and controls were similar in
terms of their type of TB (pulmonary vs. extrapulmon-
ary), hospitalization for TB treatment, history of previous
treatment failure and having treatment side effects.
Among new TB patients, cases were more likely than
controls to have taken TB treatment on an empty sto-
mach, to have seen a traditional healer while on treat-
ment for TB and to use alcohol during treatment.
Among re-treatment patients, cases were more likely
than controls to have a history of previous default.
Among both groups, cases were more likely than controls
to report that treatment did not make them feel better.
Health care team and system-related factors
Cases and controls were similar in terms of type and loca-
tion of facility they attended for treatment, their reported
access to the clinic, the number of clinics attended, and
whether they took their treatment under direct observa-
tion. Half of cases and controls reported taking treatment
without direct supervision despite the fact that they were
all enrolled in DOTS. However, the two groups reported
marked differences in opinion about experiences with
health services and the health staff during their TB treat-
ment. Cases were more likely than controls to report that
clinic hours were inconvenient, that the health care worker
(HCW) had a negative attitude towards them, did not treat
them with respect, that they did not trust the HCW and
that they missed treatment because of poor HCW attitude
(Table 4). Cases were also more likely than controls to
report that they had not received enough education about
TB at the beginning of treatment, that they were not told
why treatment would take 6 or more months and lacked
counsel and information about TB treatment in general.
Among retreatment patients, cases were more likely than
controls to report the food from the clinic would help
them finish taking their TB treatment.
Two multivariable models were created, one for new
patients and one for re-treatment patients (Table 5). Two
risk factors were independently associated with default
among both new and re-treatment patients: perception of
poor HCW attitude and changing residence during TB
treatment. Among new patients, additional risk factors
associated with default were: not receiving adequate
counseling or information during TB treatment
(Adjusted OR 1.9, 95% CI 1.2-2.8), having no formal edu-
cation (AOR 2.3, 95% CI 1.2-4.2), drinking any alcohol
during TB treatment (AOR 1.9, 95% CI 1.2-3.0), feeling
ashamed to have TB (AOR 2.0, 95% CI 1.3-3.0), and see-
ing a traditional healer during TB treatment (AOR 1.9,
95% CI 1.1-3.4). Among re-treatment patients risk factors
associated with default included: a history of previous TB
treatment default (AOR 6.4, 95% CI 2.9-14.0), not feeling
Table 1 Sex and age distribution of 231 cases and 931 controls with TB, stratified by patient category, South Africa,
2002*
New Patients (n = 926) Re-treatment Patients (n = 236)
Factor Cases
(n = 160)
Controls
(n = 766)
Stratum specific OR
(95% CI)
Cases
(n = 71)
Controls
(n = 165)
Stratum specific OR
95% CI
Sex Male 100/160 398/766 1.5 (1.1-2.2) 54/71 118/165 1.3 (0.6-2.3)
Female 60/160 368/766 1.0 17/71 47/165 1.0
Median age 30 34 p = 0.001 33 39 p = 0.003
The patient category was not documented for one case patient
*One person’s age was unknown
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Page 5 of 12better with TB treatment (AOR 21, 95% CI 5.2-84), and
agreement with the statement “food given to me by the
nurses at the clinic would better help me finish my TB
treatment” (AOR 5.0, 95% CI 1.3-19).
Discussion
TB treatment interruption often leads to poor final
treatment outcomes and drug-resistance, which has
been a challenge for the Department of Health in South
Table 2 Social and economic characteristics of cases and controls with TB, stratified by patient category, South Africa,
2002
New TB Patient (N = 926) Re-treatment TB Patient (N = 236) Combined
Cases (160) Controls
(766)
OR (95% CI) Cases (71) Controls
(165)
OR (95%
CI)
OR*(95%
CI)
AOR†
(95% CI)
Characteristic n/N % n/N % n/N % n/N %
Country of birth RSA 159/160 99 745/766 97 4.5 (0.7-186) 71/71 10 163/164 99 n/a 5.6 (0.9-231) 4.9 (0.7-36)
Outside RSA 1/160 1 21/766 3 0/71 0 1/164 1
Practices
religion
Yes 148/160 93 687/758 91 1.3 (0.7-9) 63/71 89 151/162 93 0.6 (0.2-1.7) 1.0 (0.6-1.8) 1.0 (0.6-1.7)
No 12/160 7 71/758 8 8/71 11 11/162 7
Race Black 129/159 81 661/762 86 0.7 (0.4-1.1) 57/71 80 129/164 79 1.1 (0.5-2.4) 0.7 (0.5-1.1) 0.8 (0.5-1.1)
Other 30/159 19 101/762 14 14/71 20 35/164 21
Marital status Married or
permanent
relationship
50/158 32 266/763 35 0.9 (0.6-1.3) 23/71 32 61/164 37 0.8 (0.4-1.5) 0.9 (0.6-1.2) 0.8 (0.6-1.2)
Single 108/158 68 497/763 65 48/71 68 103/164 63
Biological
children
No children 31/157 20 147/761 19 1.0 (0.6-1.6) 21/70 30 31/164 19 1.8 (0.9-3.7) 1.2 (0.9-1.8) 1.2 (0.9-1.7)
≥ 1 child 126/157 80 614/761 81 49/70 70 133/164 81
Formal
Education
None 22/160 14 61/762 8 1.8 (1.0-3.1) 5/70 7 17/164 10 0.7 (0.2-2.0) 1.4 (0.9-2.3) 1.4 (0.9-2.3)
Some 138/160 86 701/762 92 65/70 93 147/164 90
Owns a house Yes 81/157 52 386/759 51 1.0 (0.7-1.5) 37/71 52 89/164 54 0.9 (0.5-1.6) 1.0 (0.7-1.5) 1.0 (0.7-1.3)
No 76/157 48 373/759 49 34/71 48 75/164 46
Owns cattle Yes 10/157 6 31/755 4 1.6 (0.7-3.4) 2/71 3 9/164 3 0.5 (0.05-
2.5)
1.2 (0.6-2.4) 1.2 (0.6-2.3)
No 147/157 94 724/755 96 9/71 97 155/164 97
Owns radio Yes 111/158 70 500/759 66 1.2 (0.8-1.8) 45/71 63 115/164 70 0.7 (0.4-1.4) 1.1 (0.8-1.5) 1.1 (0.7-1.5)
No 47/158 30 259/759 34 26/71 27 49/164 30
Changed
residence
during TB
treatment
Yes 22/158 14 49/756 6 2.3 (1.3-4.1) 16/71 23 12/165 7 3.7 (1.5-9.1) 2.8 (1.8-4.2) 2.7 (1.7-4.2)
No 136/158 86 707/756 94 55/71 77 153/165 93
Employed Yes 81/157 52 386/759 51 1.0 (0.7-1.5) 37/71 52 89/164 54 0.9 (0.5-1.6) 1.0 (0.7-1.4) 1.0 (0.7-1.3)
No 76/157 48 373/759 49 34/71 48 75/164 46
Type of
employment
Laborer 29/83 35 88/370 24 1.7 (1.0-2.9) 13/38 34 19/81 23 1.7 (0.7-1.3) 1.7 (0.6-4.3) 1.7 (1.1-2.6)
Other 54/83 65 282/370 76 25/38 66 62/81 77
Missed
treatment due
to employment
Yes 39/85 46 16/381 4 19 (9.6-40) 14/40 35 4/80 5 10 (2.8-45) 16 (9-31) 16 (9-29)
No 46/85 54 365/381 96 26/40 65 76/80 95
In prison during
treatment
Yes 7/156 5 25/748 3 1.4 (0.5-3.3) 6/71 8 11/165 7 1.3 (0.4-4.0) 1.5 (0.7-2.9) 1.3 (0.7-2.6)
No 149/156 95 723/748 97 65/71 92 154/165 93
*Combined bivariate odds ratio
† Odds ratio adjusted for patient category
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South Africa, 2002
New TB Patient (N = 926) Re-treatment TB Patient (N = 236) Combined
Cases (160) Controls
(766)
OR
(95% CI)
Cases (71) Controls
(165)
OR (95%
CI)
OR*(95%
CI)
AOR†
(95% CI)
Characteristic n/N % n/N % n/N % n/N %
Felt ashamed about TB Yes 67/155 43 181/753 24 2.4 (1.6-3.5) 31/71 44 48/164 30 1.9 (1.0-3.5) 2.3 (1.7-3.1) 2.2 (1.6-3.0)
No 88/155 67 572/753 76 40/71 56 116/164 70
Felt supported by
family
Yes 116/153 76 651/736 88 0.4 (0.2-0.6) 54/67 80 140/160 88 0.6 (0.3-1.4) 0.5 (0.3-0.7) 0.5 (0.3-0.7)
No 37/153 24 85/736 12 13/67 20 20/160 22
Knew treatment
duration was ≥ 6
months
Yes 108/149 72 623/741 84 0.9 (0.4-2.0) 55/69 80 133/163 82 0.5 (0.3-0.8) 0.6 (0.4-0.8) 0.6 (0.4-0.8)
No 41/149 28 118/741 16 14/69 20 30/163 18
Felt they might die
from TB
Yes 96/154 62 511/749 68 0.8 (0.5-1.1) 41/65 63 118/159 74 0.6 (0.3-1.2) 0.7 (0.5-1.0) 0.7 (0.5-1.0)
No 58/154 38 238/749 32 24/65 37 41/159 26
Thought they would
finish taking treatment
Yes 112/143 78 573/734 78 1.0 (0.6-1.6) 52/63 63 130/152 74 0.8 (0.3-2.0) 1.0 (0.7-1.5) 1.0 (0.7-1.4)
No 31/143 22 161/734 22 11/63 17 22/152
Felt that it is possible
to cure TB
Yes 119/123 97 729/738 99 0.4 (0.1-1.7) 58/62 94 149/153 97 0.4 (0.1-2.2) 0.3 (0.1-0.9) 0.4 (0.2-0.9)
No 4/123 3 9/738 1 4/62 6 5/153 3
Saw a traditional healer
during TB treatment
Yes 30/159 19 52/757 7 3.2 (1.8-5.3) 9/69 13 12/165 7 1.9 (0.7-5.2) 2.8 (1.7-4.3) 2.8 (1.8-4.3)
No 129/159 18 705/757 93 60/69 87 153/165 93
Type of TB Pulmonary 150/157 96 732/749 98 0.9 (0.2-1.4) 63/69 99 157/161 98 0.3 (0.05-
1.2)
0.4 (0.2-0.9) 0.4 (0.2-0.8)
Extra
Pulmonary
7/157 4 17/749 2 6/69 1 5/161 2
Alcohol use Yes 51/154 33 157/753 21 1.9 (1.3-2.8) 27/70 39 46/163 28 1.6 (0.8-2.3) 1.9 (1.3-2.6) 1.8 (1.3-2.5)
No 103/154 77 596/753 79 43/70 61 117/163 72
Marijuana/mandrax use Yes 6/159 4 29/756 4 1.0 (0.3-2.5) 8/71 11 9/165 5 2.2 (0.7-6.7) 1.5 (0.7-2.9) 1.4 (0.7-2.6)
No 153/159 96 727/756 96 63/71 89 156/165 95
History of default No n/a n/
a
n/a n/
a
n/a 26/165 16 38/71 53 6.2 (3.1-12) n/a n/a
Yes n/a n/
a
n/a n/
a
n/a 139/165 84 33/71 47
Hospitalized for TB
treatment
Yes 54/155 35 287/758 38 0.9 (0.6-1.1) 25/70 36 66/163 40 0.8 (0.4-1.5) 0.9 (0.6-1.2) 0.9 (0.6-1.2)
No 101/155 65 471/758 62 45/70 64 97/163 60
Felt better with
treatment
No 32/150 21 15/754 2 13.3(7.0-27) 18/67 27 5/162 3 11.5 (3.9-
41)
13.3 (7.5-
24)
12.7 (7.3-
22)
Yes 118/150 79 739/754 98 49/67 73 157/162 97
Treatment side effects Yes 73/138 53 297/679 44 1.4 (1.0-2.2) 39/60 65 79/152 52 1.7 (0.9-7.8) 1.6 (1.2-2.2) 1.5 (1.1-2.1)
No 65/138 47 382/679 56 21/60 35 73/152 48
Spent ≥ 1 day without
food during treatment
Yes 28/155 18 98/759 13 1.5 (0.9-2.4) 16/70 23 30/163 18 1.3 (0.6-2.7) 1.5 (1.0-2.2) 1.4 (0.9-2.1)
No 127/155 82 661/759 87 54/70 77 133/163 82
Took TB treatment on
an empty stomach
Yes 49/142 35 183/725 25 1.6 (1.0-2.3) 24/62 39 43/160 27 1.7 (0.9-3.3) 1.6 (1.2-2.3) 1.6 (1.2-2.2)
No 93/142 65 542/729 75 38/62 61 117/160 73
*Combined bivariate odds ratio
† Odds ratio adjusted by patient category
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Page 7 of 12Africa for more than two decades. In our case control
study of TB patients treated in 2002, only 26% of cases
and 43% of controls could be traced and is an important
limitation of the study. Nevertheless, we identified sev-
eral potentially modifiable risk factors associated with
treatment default. Notably, we found an association
between default and poor perceived relations between
the HCW and patient. The importance of this relation-
ship and its influence on adherence to treatment is well
established. A few studies have reported specifically on
patient’s satisfaction with health worker attitude and
service provision and risk of default [6,11,14-16]. Vijay
et. al found similar poor provider patient relationship
factors associated with default among new smear posi-
tive TB patients [16]. Some studies have reported com-
munication barriers or poor communication between
patients and providers as being linked to poor adherence
[15,17,18]. Perceived communication quality or lack
thereof may reflect the status of the patient provider
relationship and influence patient behavior [18,19].
Other studies have reported associations between TB
treatment default and a poor level of knowledge of TB
Table 4 Health care team and system related factors, cases and controls with TB, stratified by patient category, South
Africa, 2002
New TB Patient (N = 926) Re-treatment TB Patient (N = 236) Combined
Cases (160) Controls
(766)
OR(95%
CI)
Cases (71) Controls
(165)
OR(95%
CI)
OR*(95%
CI)
AOR†
(95% CI)
Factor n/N % n/N % n/N % n/N %
Clinic hours convenient No 32/147 22 60/747 8 3.2 (1.9-5.2) 12/64 19 8/160 5 4.4 (1.5-13) 3.2 (2.1-5.0) 3.4 (2.2-5.2)
Yes 115/147 78 687/747 92 52/64 81 152/160 95
Time spent waiting at clinic ≤ 1
hour
15/146 10 74/709 10 1.0 (0.5-1.8) 9/66 14 13/154 8 1.7 (0.6-4.6) 1.1 (0.7-1.9) 1.1 (0.7-1.9)
>1
hour
131/146 90 635/709 90 57/66 86 141/154 92
Did HCW treat you with
respect?
No 11/158 7 19/761 3 2.9 (1.2-6.6) 10/71 14 3/165 2 8.9 (2.1-51) 4.1 (2.1-8.0) 4.1 (2.2-7.8)
Yes 147/158 93 742/761 97 61/71 86 162/165 98
HCW attitude Poor 17/160 11 30/763 4 2.9 (1.5-5.6) 12/71 17 5/164 3 6.5 (2.0-24) 3.6 (2.1-6.3) 3.7 (2.2-6.2)
Good 143/160 89 733/763 96 59/71 83 159/164 97
Missed treatment due to HCW
attitude
Yes 15/155 10 19/763 25 4.2 (1.9-8.9) 9/69 13 1/162 1 24.2(3.1-
1064)
5.4 (2.8-11) 5.8 (3.0-11)
No 140/155 90 744/763 75 60/69 87 161/162 99
Trusted HCW No 9/156 6 14/749 2 3.2 (1.2-8.1) 5/66 8 4/163 25 3.3 (0.7-17) 3.3 (1.5-7.2) 3.2 (1.6-6.7)
Yes 147/156 94 735/749 98 61/66 92 159/163 75
Told why TB treatment must
be taken ≥ 6 months
No 73/152 48 225/746 30 2.1 (1.5-3.1) 31/70 44 47/162 29 1.9 (1.0-3.6) 2.0 (1.5-2.8) 2.1 (1.5-3.1)
Yes 79/152 52 521/746 70 39/70 56 115/162 71
Given counsel or information
on TB treatment
No 53/155 34 163/756 22 1.9 (1.3-2.8) 27/69 39 40/164 24 2.0 (1.0-3.8) 1.9 (1.4-2.7) 1.9 (1.4-2.6)
Yes 102/155 26 593/756 78 42/69 61 124/164 76
Received enough education
about TB at beginning of
treatment
No 17/98 17 44/592 7 2.6 (1.3-4.9) 10/39 26 3/121 2 13.6 (3.1-
80)
3.5 (2.0-5.9) 3.6 (2.1-6.2)
Yes 81/98 83 548/592 93 29/39 74 118/121 88
Took pills without direct
supervision (DOT)
Yes 77/148 52 400/741 54 0.9 (0.6-1.3) 32/70 46 55/160 34 1.6 (0.8-3.0) 1.0 (0.7-1.3) 1.1 (0.8-1.4)
No 71/148 48 341/741 46 38/70 54 105/160 66
Agreed that if food was
provided by clinic, adherence
to treatment would have
been better
Yes 114/139 82 553/688 80 1.1 (0.6-1.9) 63/68 93 114/151 76 4.1 (1.4-14) 1.5 (1.0-2.4) 1.5 (1.0-2.3)
No 25/139 18 135/688 20 5/68 7 37/151 24
*Combined bivariate odds ratio
† Odds ratio adjusted by patient category
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vided concerning their illness [17-20]. Patient education
materials should be appropriately tailored to education-
level and a non-literate audience as needed.
Ensuring continuity of TB services among patients
who are mobile is challenging. Our findings that patient
mobility (changing residence) was associated with
default underscores the need for improved communica-
tion and coordination between the patient and health
services. Holtz, et. al., also found that changing resi-
dence was independently associated with MDR TB treat-
ment default among MDR TB patients in South Africa
[6]. The association between migration and default has
been cited in other settings [9,20]. Patients require edu-
cation about the ability to transfer care and TB pro-
grams should to be designed to closely follow-up and
effectively refer patients to alternate DOTS treatment
sites in a timely manner when required.
Among new TB patients, feeling shame was associated
with default. Qualitative and quantitative studies among
patients and providers have identified TB stigma as a
likely barrier to adherence [17,21-23]. The growth of the
HIV and TB co-epidemic and the well known relation-
ship between the two diseases may have intensified the
problem of TB stigma in South Africa [24]. Successful
interventions such as community education and inte-
grating community involvement in TB control may help
to reduce social barriers to treatment and stigma
[25,26].
Alcohol use was also associated with default among
new TB patients. Alcohol use or alcohol abuse has been
frequently reported as a risk factor for default
[8,9,16,27-30]. While it can be difficult for patients to
change this behavior, effective primary care behavior
interventions to reduce patient alcohol use have been
demonstrated [31,32].
The use of traditional healers is common in South
Africa. Among new patients, use of traditional healers
during TB treatment was associated with default. Several
reports have described how seeking care from traditional
healers can delay prompt diagnosis and treatment for
TB and can negatively influence morbidity and mortality
from TB [33-35]. Some TB case finding and treatment
models have successfully partnered with traditional hea-
lers to implement community-based DOTS with good
outcomes [36,37]. Every effort should be made to
expand these successful projects, educate and collabo-
rate with traditional healers and involve them in TB
control.
An association between a previous history of default
and subsequent default was found in our study and has
been reported in several other settings [38-41]. Efforts
to prevent first-time default among new patients, and
methods to rapidly identify and intervene with previous
defaulters who are at high risk are needed. As “felt bet-
ter with treatment” was also associated with default
among re-treatment patients, every effort should be
made to monitor response to therapy and manage
potential concurrent illnesses in an integrated and
timely fashion.
It is concerning that half of all patients reported that
they were not supervised when they took their TB treat-
ment. Implementation of DOT services has been a chal-
lenge in South Africa [42]. Ntshanga, et. al., conducted
an evaluation of the DOTS program in crisis districts in
KwaZulu-Natal and showed poor implementation of
DOT where low coverage, low quality and high case-
loads were associated with poorer outcomes [43].
The general health care crisis, shortage of health
workers and increased health care burden (largely from
the HIV epidemic) in South Africa has led to compro-
mises in quality of care, inadequate service delivery and
Table 5 Multivariable logistic regression analysis for TB treatment default, stratified by patient category (new, re-
treatment), South Africa, 2002*
New Patients (848) Re-treatment Patients (211)
Risk Factor Adjusted OR 95% CI Adjusted OR 95% CI
Poor HCW attitude 2.1 1.1-4.4 12 2.2-66
Changing residence during TB treatment 2.0 1.1-3.7 3.4 1.1-9.9
Did not receive adequate counseling or information 1.9 1.2-2.8
No formal education 2.3 1.2-4.2
Drank any alcohol during treatment 1.9 1.2-3.0
Felt ashamed to have TB 2.0 1.3-3.0
Saw a traditional healer for TB 1.9 1.1-3.4
History of previous TB default 6.4 2.9-14
Felt better with treatment 21 5.2-84
Agreed that if food was provided by clinic, adherence to treatment would have been better 5.0 1.3-19
*Models adjusted for age and sex; other variables considered but not included in the model: race, marital status, employment status, rural or urban setting
Finlay et al. BMC Public Health 2012, 12:56
http://www.biomedcentral.com/1471-2458/12/56
Page 9 of 12is reflected in our study findings. The variety of factors
associated with TB treatment default identified, touching
upon each of the classic adherence domains, suggests a
multi-pronged approach is needed.
Successful small scale comprehensive treatment mod-
els to improve TB treatment adherence have been evalu-
ated and documented [43-47]. Key elements of these
models include: (1) enhanced training for HCWs in
communication and counseling skills, emphasizing
patient-centered approaches; (2) development and use of
effective and appropriate patient education materials,
with an emphasis on patient adherence and self-moni-
toring tools; (3) close clinical follow-up; (4) effective
incentives; (5) social assistance programs; (6) improved
community participation, providing flexibility in DOT
provider and decentralizing treatment through commu-
nity based DOTS; (7) integrated TB and HIV care; (8)
enhanced program supervision and management; and
(9) adequate financial and human resources.
There were several limitations of this study. The low
response rate limits power to draw generalized conclu-
sions about South Africa. Other retrospective case con-
trol studies have reported similar difficulties in locating
patients after they have left care at the TB program,
especially defaulters [6,15-17,48-50]. The retrospective
nature of the study and self-reported data collected
from patients is subject to recall bias which may reduce
the risk estimate. Cases interviewed were more likely to
default later in the treatment course than those not
interviewed. Because there is an unknown temporal
association between the risk factors identified and treat-
ment default, this limits our ability to potentially identify
time-points in case management at which different risk
factors for non-adherence are more important and
where specific types of adherence strategies may have an
increased impact.
Lastly, there are inherent difficulties in collecting sub-
jective data between such disparate subjects as social
factors, economic factors, health care team characteris-
tics, and patient-level factors all reported through one
mechanism, the patient self-report. The self-report refers
to experience, rather than to reality. It is the experience
(of reality and not reality itself) that informs future deci-
sions by people about adherence and retention. Hence if
we are interested in understanding the relationship
between satisfaction and adherence, we need to know
patient subjective experiences. The same applies to
experiences that are quantifiable and can actually be
verified from institutional data, such as the number of
doctors seen, waiting times, etc. Also here the subjective
experience is the overarching factor when it comes to
making decisions by patients. Some of these factors we
measured have direct impact on health care services,
and others have indirect but equally large impacts on
services. Unfortunately it was also not possible to
include the provider perspective (health care workers
and treatment supporters) on default and non-adher-
ence in this study.
Conclusion
Standard 9 of the International Standards of Tuberculo-
sis Care includes creating a treatment environment to
promote adherence and monitoring results using a
patient centered approach and fostering respect between
the patient and provider [51]. There are now several
small scale models incorporating patient-centered
approaches showing success at achieving good TB treat-
ment outcomes in local settings in South Africa and
other countries. Adequate resources, good program
management, supervision and ongoing evaluation are
urgently needed to ensure successful scale up and sus-
tainability of these programs. While South Africa faces
challenges of an overburdened health system amidst the
escalating TB/HIV co-epidemic, the country has made
policy changes and begun implementing innovative ways
to reduce staff shortages, improve staff motivation,
develop new approaches to clinical practice and educa-
tion [52]. These promising changes provide a fertile
ground on which to institute interventions to reduce
default from TB treatment.
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